| Unique ID issued by UMIN | UMIN000060482 |
|---|---|
| Receipt number | R000069146 |
| Scientific Title | Exploratory Analysis of Disease and Treatment Burden for Patients with Hypoparathyroidism: A Qualitative Study of Effects on Daily Life |
| Date of disclosure of the study information | 2026/04/20 |
| Last modified on | 2026/03/26 14:48:59 |
Exploratory Analysis of Disease and Treatment Burden for Patients with Hypoparathyroidism: A Qualitative Study of Effects on Daily Life
Exploratory Analysis of Disease and Treatment Burden for Patients with Hypoparathyroidism: A Qualitative Study of Effects on Daily Life
Exploratory Analysis of Disease and Treatment Burden for Patients with Hypoparathyroidism: A Qualitative Study of Effects on Daily Life
Exploratory Analysis of Disease and Treatment Burden for Patients with Hypoparathyroidism: A Qualitative Study of Effects on Daily Life
| Japan |
Hypoparathyroidism
| Endocrinology and Metabolism |
Others
NO
To clarify the disease burden (physical, psychological, and social aspects) and treatment burden (conventional treatment problems) faced by patients with hypoparathyroidism in this study.
Others
Evaluating QOL, worries, and physical, psychological, and social burdens from the patient's perspective.
Exploratory
Others
Not applicable
- Burden of Disease (Physical, Emotional, and Social Aspects)
- Treatment Burden (Traditional Pain Points)
Observational
| 18 | years-old | <= |
| Not applicable |
Male and Female
Upon obtaining informed consent:
(1) Patients >= 18 years of age
(2) patients with a confirmed diagnosis of hypoparathyroidism
(3) Previously treated with activated vitamin D
(4) Patients with laboratory data for serum calcium, * serum phosphorus, and intact PTH
(5) Patients who can voluntarily consent to participate in the study
*Basically, an albumin-corrected value will be used, but if not available, a corrected calcium value will be calculated from the serum calcium value using Payne's formula.
- Payne's formula: corrected Ca level (mg/dL) = measured Ca level (mg/dL) + (4 -Alb level (g/dL))
At enrollment:
(1) Experienced distress due to hypoparathyroidism
Upon obtaining informed consent:
(1) Diagnosis of pseudohypoparathyroidism
(2) Patients considered by physician to be ineligible
10
| 1st name | Kenji |
| Middle name | |
| Last name | Ashida |
Department of Internal Medicine, Kurume University School of Medicine
Division of Endocrine and metabolic disease
830 0011
67 Asahi machi, Kurume shi, Fukuoka 830 0011, Japan
0942-31-7563
ashida@med.kurume-u.ac.jp
| 1st name | Kenji |
| Middle name | |
| Last name | Ashida |
Department of Internal Medicine, Kurume University School of Medicine
Division of Endocrine and metabolic disease
830 0011
67 Asahi machi, Kurume shi, Fukuoka 830 0011, Japan
0942-31-7563
ashida@med.kurume-u.ac.jp
Kurume University
Teijin Pharma Limited
Profit organization
Japan
Kurume University Medical Ethics Committee
67 Asahi machi, Kurume shi, Fukuoka 830 0011, Japan
0942-35-3311
i_rinri@kurume-u.ac.jp
NO
久留米大学(福岡県)
| 2026 | Year | 04 | Month | 20 | Day |
Unpublished
Preinitiation
| 2026 | Year | 01 | Month | 07 | Day |
| 2026 | Year | 04 | Month | 01 | Day |
| 2026 | Year | 09 | Month | 30 | Day |
This study is a qualitative study using cross-sectional, non-interventional, semi-structured interviews. Our goal is to conduct and analyze interviews with at least 10 patients with hypoparathyroidism.
| 2026 | Year | 01 | Month | 27 | Day |
| 2026 | Year | 03 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069146